Accuray Incorporated (ARAY) Financials
ARAY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 476.4 million | 428.7 million |
2023-09-30 | 476.8 million | 425.9 million |
2023-06-30 | 479.2 million | 425.6 million |
2023-03-31 | 475.7 million | 421.0 million |
ARAY Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.3 million | 2.3 million |
2023-09-30 | -9.7 million | 2.4 million |
2023-06-30 | 846000 | 2.5 million |
2023-03-31 | 22.8 million | 1.6 million |
ARAY Net Income
No data available :(
ARAY Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 72.8 million | - | 27.5 million |
2023-09-30 | 76.9 million | - | 28.9 million |
2023-06-30 | 89.4 million | - | 27.8 million |
2023-03-31 | 89.1 million | 172.8 million | 26.5 million |
ARAY Shares Outstanding
ARAY Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.2 million | 15.3 million | 13.2 million | 11.4 million |
2023-09-30 | 1.1 million | 14.0 million | 13.0 million | 10.2 million |
2023-06-30 | 8.0 million | 14.2 million | 13.3 million | 10.7 million |
2023-03-31 | 1.8 million | 14.2 million | 11.1 million | 11.1 million |
ARAY Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 107.2 million | 71.3 million |
2023-09-30 | 103.9 million | 64.4 million |
2023-06-30 | 118.3 million | 80.6 million |
2023-03-31 | 118.1 million | 79.3 million |
ARAY
Price: $2.19
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -17.20
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 811938
Ebitda: 1.5 millionMarket Capitalization: 226.1 million